Inhibition of IL-32 and TSLP production through the attenuation of caspase-1 activation in an animal model of allergic rhinitis by Naju Jjok (Polygonum tinctorium)

International Journal of Molecular Medicine

Volumn 33, Issue 1, 2014, Pages 142-150

  Jeong, Hyun Ja ^a   Oh, Hyun A ^b   Lee, Byung Joo ^b   Kim, Hyung Min ^b  

^a Hoseo University   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Allergic rhinitis; Interleukin 32; Naju Jjok; Polygonum tinctorium Lour.; Thymic stromal lymphopoietin

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 32; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; OVALBUMIN; PLANT EXTRACT; POLYGONUM TINCTORIUM EXTRACT; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HISTAMINE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MAST CELL; MOUSE; NONHUMAN; POLYGONUM; POLYGONUM TINCTORIUM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SPLEEN WEIGHT; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANIMALS; CASPASE 1; CELL LINE; CHEMOKINE CXCL2; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HISTAMINE; HUMANS; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-GAMMA; INTERLEUKINS; MAST CELLS; MICE; MICE, INBRED BALB C; OVALBUMIN; PLANT EXTRACTS; POLYGONUM; RHINITIS, ALLERGIC, PERENNIAL; SPLEEN;

EID: 84892688010     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1548     Document Type: Article

References (44)

1. Varney VA, Jacobson MR, Suddarick RM, et al: Immunohistology of nasal mucosa following allergen induced rhinitis. Am Rev Respir Dis 146: 170-175, 1992.
2. Sim TC, Grant JA, Hilsmeier KA, Fukuda Y and Alam R: Pro-inflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med 149: 339-344, 1994.
3. Gupta S, Feng L, Yoshimura T, Redick J, Fu SM and Rose CE Jr: Intra-alveolar macrophage-inflammation peptide 2 induces rapid neutrophil localization in the lung. Am J Respir Cell Mol Biol 15: 656-663, 1996.
4. Durham SR, Ying S, Varney VA, et al: Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophase colony stimulating factors in the nasal mucosa after local allergen provocation. J ImmunoI 148: 2390-2394, 1992.
5. Bacon AS, McGill JI, Anderson DF, Baddeley S, Lightman SL and Holgate ST: Adhesion molecules and relationship to leukocyte levels in allergic eye disease. Invest Ophthalmol Vis Sci 39: 322-330, 1998.
6. Tai PC and Spry CJ: The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils. Clin Exp Immunol 80: 426-434, 1990.
7. Jeong HJ, Shin SY, Oh HA, Kim MH, Cho JS and Kim HM: IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J Path 224: 553-563, 2011.
8. Marcondes AM, Mhyre AJ, Stirewalt DL, Kim SH, Dinarello CA and Deeg HJ: Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function. Proc Natl Acad Sci USA 105: 2865-2870, 2008.
9. Bae S, Kang D, Hong J, et al: Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection. Cytokine 58: 79-86, 2012.
10. Heinhuis B, Koenders MI, van Riel PL, et al: Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade. Ann Rheum Dis 70: 660-667, 2011.
11. Kim SH, Han SY, Azam T, Yoon DY and Dinarello CA: Interleukin-32: a cytokine and inducer of TNF alpha. Immunity 22: 131-142, 2005.
12. Netea MG, Azam T, Ferwerda G, et al: IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 102: 16309-16314, 2005.
13. Nishida A, Andoh A, Shioya M, Kim-Mitsuyama S, Takayanagi A and Fujiyama Y: Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts. Am J Physiol Gastrointest Liver Physiol 294: G831-G838, 2008.
14. Heinhuis B, Koenders MI, van den Berg WB, Netea MG, Dinarello CA and Joosten LA: IL-32 contains a typical alpha-helix bundle structure that resembles the focal adhesion targeting region of focal adhesion kinase-1. J Biol Chem 287: 5733-5743, 2012.
15. Ying S, O'Connor B, Ratoff J, et al: Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol 181: 2790-2798, 2008.
16. Soumelis V, Reche PA, Kanzler H, et al: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3: 673-680, 2002.
17. Bunyavanich S, Melen E, Wilk JB, et al: Thymic stromal lymphopoietin (TSLP) is associated with allergic rhinitis in children with asthma. Clin Mol Allergy 9: 1, 2011.
18. Moon PD and Kim HM: Thymic stromal lymphopoietin is expressed and produced by caspase-1/NF-κB pathway in mast cells. Cytokine 54: 239-243, 2011.
19. Song YH, Nam SY, Choi Y, Kim JH, Kim YS and Jeong HJ: Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug. TANG 2: 52-60, 2012.
20. Jeong HJ, Nam SY, Oh HA, et al: Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro. Arthritis Res Ther 14: R259, 2012.
21. Iwaki K, Satomi KM, Kohno K, Ushio S and Fukuda S: Antimicrobial activity of Polygonum tinctorium Lour: extract against oral pathogenic bacteria. J Nat Med 60: 121-125, 2006.
22. Satomi KM, Kimoto T, Micallef MJ, et al: Prevention of azoxymethane-induced intestinal tumors by a crude ethyl acetate-extract and tryptanthrin extracted from Polygonum tinctorium Lour. Anticancer Res 21: 3295-3300, 2001.
23. Kataoka M, Hirata K, Kunikata T, et al: Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbils. J Gastroenterol 36: 5-9, 2001.
24. Kim HM, Hong DR, and Lee EH: Inhibition of mast cell-dependent anaphylactic reactions by the pigment of Polygonum tinctorium (Chung-Dae) in rats. Gen Pharmacol 31: 361-365, 1998.
25. Miyata M, Hatsushika K, Ando T, et al: Mast cell regulation of epithelial TSLP expression plays an important role in the development of allergic rhinitis. Eur J Immunol 38: 1487-1492, 2008.
26. Han NR, Kim HM and Jeong HJ: Thymic stromal lymphopoietin is regulated by the intracellular calcium. Cytokine 59: 215-217, 2012.
27. Spada CS, Nieves AL, Krauss AH and Woodward DF: Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol 55: 183-191, 1994.
28. Sugimoto H, Shichijo M, Iino T et al: An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J Pharmacol Exp Ther 305: 347-352, 2003.
29. Melvin TA and Ramanathan M Jr: Role of innate immunity in the pathogenesis of allergic rhinitis. Curr Opin Otolaryngol Head Neck Surg 20: 194-198, 2012.
30. Isobe Y, Kato T and Arita M: Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation. Front Immunol 3: 270, 2012.
31. Moshkovits I, Shik D, Itan M, et al: CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis. Mucosal Immunol: Jul 3, 2013 (Epub ahead of print). doi: 10.1038/mi.2013.47.
32. Bystrom J, Patel SY, Amin K and Bishop-Bailey D: Dissecting the role of eodinophil cationic protein in upper airway disease. Curr Opin Allergy Clin Immunol 12: 18-23, 2012.
33. Soyka MB, Treis A, Eiwegger T, et al: Regulation and expression of IL-32 in chronic rhinosinusitis. Allergy 67: 790-798, 2012.
34. Nomura K, Kojima T, Fuchimoto J, Obata K, Keira T, Himi T and Sawada N: Regulation of interleukin-33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines. Laryngoscope 122: 1185-1192, 2012.
35. Oh HA, Kim HM and Jeong HJ: Alleviation of allergic rhinitis symptoms with Pyeongwee-San extract (KMP6). Immunopharmacol Immunotoxicol 34: 135-142, 2012.
36. Vashisht P and Casale T: Omalizumab for treatment of allergic rhinitis. Expert Opin Biol Ther 13: 933-945, 2013.
37. Sollberger G, Strittmatter GE, Garstkiewicz M, Sand J and Beer HD: Caspase-1: the inflammasome and beyond. Innate Immun: May 15, 2013 (Epub ahead of print).
38. Grzegorczyk J, Kowalski ML, Pilat A and Iwaszkiewicz J: Increased apoptosis of peripheral blood mononuclear cells in patients with perennial allergic asthma/rhinitis: relation to serum markers of apoptosis. Mediators Inflamm 11: 225-233, 2002.
39. Han NR, Kim HM and Jeong HJ: Kanamycin activates caspase-1 in NC/Nga mice. Exp Dermatol 20: 659-663, 2011.
40. Cunha TM, Talbot J, Pinto LG, et al: Caspase-1 is involved in the genesis of inflammatory hypernociception by contributing to peripheral IL-1β maturation. Mol Pain 6: 63, 2010.
41. Lee EJ, Ji GE and Sung MK: Quercetin and kaempferol suppress immunoglobulin E-mediated allergic inflammation in RBL-2H3 and Caco-2 cells. Inflamm Res 59: 847-854, 2010.
42. Gong JH, Shin D, Han SY, Kim JL and Kang YH: Kaempferol suppresses eosionphil infiltration and airway inflammation in airway epithelial cells and in mice with allergic asthma. J Nutr 142: 47-56, 2012.
43. Kunikata T, Tatefuji T, Aga H, Iwaki K, Ikeda M and Kurimoto M: Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity. Eur J Pharmacol 410: 93-100, 2000.
44. Kim MH, Choi YY, Yang G, Cho IH, Nam D and Yang WM: Indirubin, a purple 3,2-bisindole, inhibited allergic contact dermatitis via regulating Thelper(Th)-mediated immune system in DNCB-induced model. J Ethnopharmacol 145: 214-219, 2013.